Armstrong, A. W.; Hee Park, S.; Chirikov, V.; Nicolas, P.; Wang, W.-J.; Colombo, M. J.; Patel, V. Optimizing the Treatment Sequence: The Cumulative Clinical Benefit of Treatment Initiation With Deucravacitinib Versus Apremilast over 52 Weeks in Patients With Moderate to Severe Plaque Psoriasis from the POETYK PSO-1 Trial. J of Skin 2022, 6, s62.